美元看涨基金-Bloomberg USDU 深 沪
等待开盘 03-26 09:30:00 美东时间
26.26
+0.080
+0.31%
华盛通- 最 高26.26
- 今 开26.16
- 成交量 14.12万股
- 最 低 26.16
- 昨 收 26.18
- 总市值 1.77亿
- 52周最高 26.38
- 市盈率 静 --
- 换手率 2.09%
- 52周最低 24.7115
- 委 比 0.00%
- 总股本 675.00万
- 历史最高 27.2514
- 量 比 0.38
- 振 幅 0.38%
- 历史最低 16.302
- 每 手 1
- 风险率 0.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trump Cheers Weaker Dollar, But Foreign Buyers Feel The Pain: PIMCO Sees Negative Yields As Campbell Says Sell Assets, Not The Greenback
Trump cheers a falling dollar, but PIMCO warns foreign bond buyers face negative yields. Expert Campbell says: Sell US bonds, keep cash.
01-29 21:27
US Losing Ability To 'Tax The World' To Fund Deficits, Warns Thomas Massie Amid Diminishing Dollar Dominance
Rep. Thomas Massie warns the US is losing its ability to "tax the world" via the dollar, leaving people to face the full cost of inflation.
01-19 17:19
Ray Dalio Warns All Fiat Currencies Are In 'Trouble,' Says 'Money Is Debt' and Predicts a Major Devaluation Cycle
Ray Dalio warns fiat currencies are "in trouble" due to soaring global debt. Read why the billionaire predicts a major devaluation cycle.
2025-12-30 19:15
Gold glitters, bitcoin booms: Deutsche Bank highlights shift away from dollar dependence
Deutsche Bank’s investment research team highlighted a notable shift in global asset preferences, as both gold (XAUUSD:CUR) and bitcoin (BTC-USD) increasingly attract investor attention amid waning co...
2025-10-07 23:57
UroGen Pharma Announces Positive Clinical Results for ZUSDURI™ in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer
UroGen Pharma Ltd. has announced the publication of a comprehensive clinical review of ZUSDURI™ (mitomycin) for intravesical solution, the first and only FDA-approved medication for adults with recurr...
2025-10-02 20:00
US Dollar Down 10% Since Trump Took Office — Paul Graham Warns 'You've Become Poorer' Without 11% Net Worth Gain
Y Combinator co-founder Paul Graham warned on Thursday that Americans need an 11% increase in net worth just to maintain purchasing power.
2025-08-07 18:23
BRIEF-UroGen Reports 72.2% 24-Month Response in Phase 3 Trial of FDA-Approved Zusduri
Aug 5 (Reuters) - Urogen Pharma Ltd UR8.F: UROGEN ANNOUNCES 24-MONTH DURATION OF RESPONSE OF 72.2% FROM THE PIVOTAL PHASE 3 ENVISION TRIAL OF ZUSDURI, THE FIRST AND ONLY FDA-APPROVED MEDICINE FOR RECU...
2025-08-05 21:08
U.S. Treasury yields slide, dollar index plunges amid jitters over Fed independence
U.S. Treasury yields fell on Wednesday as traders snapped up bonds, while the dollar index turned negative and slid, sparked by concerns over monetary policy independence after reports that U.S. Presi...
2025-07-16 23:47
Chamath Palihapitiya Shrugs Off Dollar's 11% Slide In Worst Half-Century Drop, Says 'Decay Continues' Without Total Collapse
Chamath Palihapitiya believes US dollar's long-term decline is not concerning due to consistent demand for dollar-denominated assets offsetting depreciation.
2025-07-09 18:32
BRIEF-Urogen Pharma Says Zusduri Expected To Be Available In U.S. By July 1
June 12 (Reuters) - Urogen Pharma Ltd UR8.F: U.S. FDA APPROVES UROGEN’S ZUSDURI™ (MITOMYCIN) FOR INTRAVESICAL SOLUTION AS THE FIRST AND ONLY MEDICATION FOR RECURRENT LOW-GRADE INTERMEDIATE-RISK NON-MU...
2025-06-13 01:30
